Stay updated on ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial
Sign up to get notified when there's something new on the ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial page.

Latest updates to the ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial page
- Check7 days agoChange DetectedThe displayed ClinicalTrials.gov revision changed from v3.7.2 to v3.8.0. The page still shows a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check14 days agoChange DetectedA site-wide notice says NIH is transitioning terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check21 days agoChange DetectedThe ClinicalTrials.gov error page shows an updated site revision identifier in its footer.SummaryDifference0.2%

- Check28 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check49 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the expected content with an access-denied message.SummaryDifference19%

- Check70 days agoChange DetectedA new funding line '2016 ( U.S. NIH Grant/Contract )' was added and the page's revision history now shows 'Revision: v3.6.6', while the previous revision 'Revision: v3.6.5' was removed.SummaryDifference0.1%

Stay in the know with updates to ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARIEL4 Rucaparib vs Chemotherapy in BRCA Mutant Ovarian Clinical Trial page.